We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current MEDP market cap is 12.12B. The company's latest EPS is USD 9.1943 and P/E is 42.88.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 434.07M | 460.87M | 492.5M | 498.4M | 511.04M |
| Operating Income | 86.2M | 78.39M | -245.93M | 87.32M | 104.07M |
| Net Income | 72.89M | 61.07M | 70.55M | 78.3M | 102.59M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 860.97M | 925.93M | 1.14B | 1.46B | 1.89B |
| Operating Income | 127.26M | 167.04M | 198.62M | 278.7M | 336.83M |
| Net Income | 100.44M | 145.38M | 181.85M | 245.37M | 282.81M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.4B | 1.41B | 1.49B | 1.66B | 1.8B |
| Total Liabilities | 1.05B | 1.02B | 1.02B | 1.1B | 1.12B |
| Total Equity | 347.26M | 391.06M | 470.91M | 558.95M | 671.54M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.14B | 1.39B | 1.66B | 1.35B | 1.66B |
| Total Liabilities | 416.79M | 584.9M | 707.01M | 966.11M | 1.1B |
| Total Equity | 726.28M | 805.78M | 952.93M | 386.39M | 558.95M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 80.08M | 162.59M | 276.98M | 433.37M | 152.68M |
| Investing | -9.5M | -17.97M | -26.63M | -34.63M | 2.53M |
| Financing | -52.68M | -134.89M | -184.17M | -182.64M | 7.66M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 201.87M | 258.68M | 263.33M | 388.05M | 433.37M |
| Investing | -19.14M | -31.21M | -31.36M | -38.74M | -34.63M |
| Financing | -73.92M | -82.28M | -44.45M | -775.78M | -182.64M |
| Market Cap | 12.12B |
| Price to Earnings Ratio | 42.88 |
| Price to Sales Ratio | 6.43 |
| Price to Cash Ratio | 49.41 |
| Price to Book Ratio | 21.7 |
| Dividend Yield | - |
| Shares Outstanding | 30.76M |
| Average Volume (1 week) | 163.08k |
| Average Volume (1 Month) | 162.7k |
| 52 Week Change | 79.87% |
| 52 Week High | 421.00 |
| 52 Week Low | 214.32 |
| Spread (Intraday) | 17 (4.26%) |
| Company Name | Medpace Holdings Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.medpace.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
